|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.730 CNY | -0.52% |
|
+4.37% | -22.25% |
| 02/06 | Beijing SL Pharmaceutical Co., Ltd. Approves Cash Dividend for 2025 | CI |
| 07/05 | Beijing SL Pharmaceutical Gets China Regulatory Nod for Xinfer Drug | MT |
| Market Cap | 588.67Cr 87Cr 76Cr 70Cr 65Cr 122.23Cr 8.29TCr 123.6Cr 827.26Cr 324.69Cr 4.15TCr 327.49Cr 320.27Cr 14TCr | P/E 2024 |
-107x | P/E 2025 | -21.7x |
|---|---|---|---|---|---|
| Enterprise Value | 474.54Cr 70Cr 61Cr 57Cr 52Cr 99Cr 6.68TCr 100Cr 666.87Cr 261.74Cr 3.34TCr 263.99Cr 258.17Cr 11TCr | EV / Sales 2024 |
8.62x | EV / Sales 2025 | 10.3x |
| Free-Float |
59.66% | Yield 2024 |
0.27% | Yield 2025 | 0.14% |
| 1 day | -0.52% | ||
| 1 week | +4.37% | ||
| Current month | +1.96% | ||
| 1 month | -10.33% | ||
| 3 months | -11.71% | ||
| 6 months | -12.92% | ||
| Current year | -22.25% |
| 1 week | 5.33 |  | 5.82 |
| 1 month | 5.2 | | 7.33 |
| Current year | 4.81 | | 9.4 |
| 1 year | 4.81 | | 9.4 |
| 3 years | 4.81 | | 16.09 |
| 5 years | 4.81 | | 16.09 |
| 10 years | 4.81 | | 33.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CEO | Chief Executive Officer | 62 | 11/04/2006 |
Li Ji
DFI | Director of Finance/CFO | 45 | 24/04/2023 |
Shu Jie Liang
SEC | Corporate Secretary | 60 | 11/04/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CHM | Chairman | 62 | 11/04/2006 |
Shu Jie Liang
BRD | Director/Board Member | 60 | 24/04/2009 |
Yu Lin Chen
BRD | Director/Board Member | 81 | 11/04/2006 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05/11/25 | Buy | Director | 100 | 0.0000% | ||
| 29/10/25 | Sell | Director | 35,100 | 0.0041% | ||
| 28/10/25 | Sell | Director | 3,40,000 | 0.0399% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.52% | +4.37% | -31.70% | -39.30% | 88Cr | |
| +3.86% | -4.18% | +51.37% | +155.34% | 99TCr | |
| +1.35% | -2.77% | +51.21% | +49.15% | 61TCr | |
| +0.80% | -6.65% | +23.80% | +63.51% | 43TCr | |
| +1.96% | +0.83% | +42.80% | +37.70% | 35TCr | |
| -0.11% | -4.07% | +30.37% | +38.52% | 29TCr | |
| +2.52% | -8.36% | +7.27% | +10.56% | 24TCr | |
| +3.67% | +4.44% | +34.92% | +60.06% | 21TCr | |
| -4.32% | -12.94% | -3.79% | -46.07% | 21TCr | |
| -2.41% | -1.36% | +16.41% | +62.29% | 17TCr | |
| Average | +0.73% | -3.87% | +22.27% | +39.18% | 35.19TCr | |
| Weighted average by Cap. | +1.68% | -5.89% | +36.34% | +71.80% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 66Cr 9.78Cr 8.47Cr 7.9Cr 7.26Cr 14Cr 930.16Cr 14Cr 93Cr 36Cr 465.41Cr 37Cr 36Cr 1.54TCr | 62Cr 9.24Cr 8Cr 7.46Cr 6.86Cr 13Cr 878.37Cr 13Cr 88Cr 34Cr 439.49Cr 35Cr 34Cr 1.46TCr |
| Net income | -7.41Cr -1.1Cr -95.02L -88.57L -81.46L -1.54Cr -104.32Cr -1.56Cr -10Cr -4.09Cr -52Cr -4.12Cr -4.03Cr -172.87Cr | -35Cr -5.14Cr -4.45Cr -4.15Cr -3.82Cr -7.21Cr -489.01Cr -7.29Cr -49Cr -19Cr -244.67Cr -19Cr -19Cr -810.34Cr |
| Net Debt | -198.23Cr -29Cr -25Cr -24Cr -22Cr -41Cr -2.79TCr -42Cr -278.57Cr -109.33Cr -1.4TCr -110.28Cr -107.85Cr -4.63TCr | -114.13Cr -17Cr -15Cr -14Cr -13Cr -24Cr -1.61TCr -24Cr -160.39Cr -63Cr -804.31Cr -63Cr -62Cr -2.66TCr |
Employees
901
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/26/05 | CN¥5.730 | -0.52% | 2,66,67,690 |
| 04/26/04 | CN¥5.760 | +1.77% | 2,77,50,660 |
| 03/26/03 | CN¥5.660 | +0.71% | 1,99,09,637 |
| 31/26/31 | CN¥5.620 | +4.46% | 3,61,96,367 |
| 30/26/30 | CN¥5.380 | -2.00% | 3,43,26,701 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 002038 Stock
Select your edition
All financial news and data tailored to specific country editions
